GlassScriptPhysician profile
Norton Winer
NPI 1194826552
$38,881.52
in general payments reported to CMS, 2019-2025
44 companies · $1,323 in 2025
The $1,323 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $6,784 · 2021: $4,630 · 2022: $4,126 · 2023: $14.47 · 2024: $500 · 2025: $1,323.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $950 · Consulting Fee: $650 · Food and Beverage: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $949.88 |
| Consulting Fee | $650.00 |
| Food and Beverage | $238.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $18,287.36 | 2019-2022 | |
| Biogen, INC. | $6,047.90 | 2019-2025 | Tysabri |
| Livanova USA, INC. | $5,860.19 | 2019-2025 | Vns Therapy, Vns Therapy Sentiva Model 1000 Generator |
| Novartis Pharmaceuticals Corporation | $1,248.68 | 2019-2022 | |
| Genzyme Corporation | $1,086.43 | 2019-2022 | |
| Banner Life Sciences, LLC | $900.00 | 2021 | |
| Tg Therapeutics, INC. | $500.00 | 2024 | |
| Lilly USA, LLC | $465.63 | 2019-2022 | |
| Ucb, INC. | $458.98 | 2019-2022 | |
| Emd Serono, INC. | $315.72 | 2019-2020 | |
| Kyowa Kirin, INC. | $302.63 | 2020-2022 | |
| Genentech USA, INC. | $287.00 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $244.44 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $222.69 | 2019-2022 | |
| Lundbeck LLC | $196.69 | 2019-2022 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Norton Winer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.